Envision Healthcare
EVHC
Delayed Nyse - 12/13 09:20:59 pm
33.21USD
-0.57%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Sales3 6967 779
EBITDA631896
Operating profit (EBIT)568764
Pre-Tax Profit (EBT)--
Net income-27,7-344
EPS ( $ )-0,47-1,60
Dividend per Share ( $ )--
Yield--
Announcement Date02/28/2017
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 20162017
Debt5 5075 450
Finance--
Operating income (EBITDA)631896
Leverage
(Debt/EBITDA)
8,73x6,08x
Capital Expenditure99,5146
Book Value Per Share (BVPS)57,3 $55,9 $
Cash Flow per Share6,66 $6,88 $
Announcement Date02/28/2017
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2017e 2018e
Capitalization 4 041 M$ -
Entreprise Value (EV) 9 491 M$ 9 116 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 13,6x
Capitalization / Revenue 0,52x 0,49x
EV / Revenue 1,22x 1,10x
EV / EBITDA 10,6x 9,61x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,60x 0,58x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 9,82% 10,2%
operating Leverage (Delta EBIT / Delta Sales) 0,31x 1,67x
Net Margin (Net Profit / Revenue) -4,42% 3,17%
ROA (Net Profit / Asset) 2,48% 2,80%
ROE (Net Profit / Equities) 5,04% 5,16%
Rate of Dividend - -
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,88% 1,06%
Cash Flow / Sales 10,7% 6,07%
Capital Intensity (Assets / Sales) -1,79x 1,13x
Financial Leverage (Net Debt / EBITDA) 6,08x 5,35x
Price Earning Ratio
BNA & Dividende